Benzodiazepine discontinuation syndromes.
Greenblatt
D J
DJ
Division of Clinical Pharmacology, Tufts University School of Medicine, Boston, MA.
Miller
L G
LG
Shader
R I
RI
D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D001569:Benzodiazepines; D006801:Humans; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines